As the NHS Long Term Plan is published - some messages of hope from people with rare and less common cancer for 2019 and beyond …. a...

Slides from the recent Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Pharmaceutical...

It was great to see some of you at the Britain Against Cancer conference on 4 December and thank you to those of you – or your patients -...

Cancer52, together with use MY data, have jointly produced a briefing document on what The National Data Opt-out means for cancer...

We are delighted that Cancer52 features in this month's New Statesman's Oncology Supplement, published to coincide with this year's...

We are pleased to announce that Cancer52 is recruiting trustees to its board to support the future development and growth of the...

In June, at the PHE Cancer Services, Data and Outcomes Conference 2018, Cancer52 worked with the National Cancer Registration and...

When a person is diagnosed with cancer in the UK information about them is automatically included in their national cancer registry. It...

The annual All Stakeholder Briefing was held on 17 October 2018. We were honoured that Cally Palmer, National Cancer Director, NHS...

We're excited to announce the publication of our new briefing document 'Getting a better deal for people with rare and less common...